(VIANEWS) – CBO TERRITORIA (CBOT.PA), ENGIE (ENGI.PA), KBC (KBC.BR) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| CBO TERRITORIA (CBOT.PA) | 6.43% | 2023-03-29 07:46:07 |
| ENGIE (ENGI.PA) | 6.06% | 2023-03-29 07:48:07 |
| KBC (KBC.BR) | 4.94% | 2023-03-29 07:15:39 |
| SANOFI (SAN.PA) | 3.47% | 2023-03-29 07:02:47 |
| ROTHSCHILD & CO (ROTH.PA) | 3% | 2023-03-29 04:03:22 |
| CEGEDIM (CGM.PA) | 2.91% | 2023-03-29 07:46:09 |
Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. CBO TERRITORIA (CBOT.PA)
6.43% Foward Dividend Yield
CBO TERRITORIA’s last close was €3.71, 5.36% below its 52-week high of €3.92. Intraday change was -0.13%.
CBo Territoria SA engages in the urban planning and development, and property development and investment activities in France. The company develops and sells housings, offices, buildings, retail parks, shopping centers, business premises, and warehouses. It is also involved in the leisure, marketing, and coworking businesses. In addition, the company also owns approximately 3,000 hectares of land in Réunion Island. CBo Territoria SA was founded in 2004 and is headquartered in Sainte-Marie, France.
Earnings Per Share
As for profitability, CBO TERRITORIA has a trailing twelve months EPS of €0.41.
PE Ratio
CBO TERRITORIA has a trailing twelve months price to earnings ratio of 9.04. Meaning, the purchaser of the share is investing €9.04 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.52%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CBO TERRITORIA’s stock is considered to be oversold (<=20).
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jun 14, 2022, the estimated forward annual dividend rate is 0.24 and the estimated forward annual dividend yield is 6.43%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 8.4%, now sitting on 82.83M for the twelve trailing months.
Yearly Top and Bottom Value
CBO TERRITORIA’s stock is valued at €3.71 at 17:50 EST, under its 52-week high of €3.92 and higher than its 52-week low of €3.42.
More news about CBO TERRITORIA.
2. ENGIE (ENGI.PA)
6.06% Foward Dividend Yield
ENGIE’s last close was €13.93, 5.11% below its 52-week high of €14.68. Intraday change was 1.71%.
ENGIE SA engages in the power, natural gas, and energy services businesses. It operates through Renewables, Networks, Energy Solutions, Thermal, Supply, Nuclear, and Others segments. The Renewables segment comprises renewable energy generation activities, including financing, construction, operation, and maintenance of renewable energy facilities using various energy sources, such as hydroelectric, onshore wind, photovoltaic solar, biomass, offshore wind, and geothermal. The Networks segment comprises the electricity and gas infrastructure activities and projects, including the management and development of gas and electricity transportation networks and natural gas distribution networks in and outside of Europe, natural gas underground storage in Europe, and regasification infrastructure in France and Chile. The Energy Solutions encompasses the construction and management of decentralized energy networks to produce low-carbon energy and related services. The Thermal segment encompasses power generation activities using thermal assets; operation of power plants fueled mainly by gas or coal, as well as pump -operated storage plants; and financing, construction, and operation of desalination plants, as well as the development of hydrogen production. The Supply segment engages in the sale of gas and electricity to professional, individual, and residential clients. The Nuclear segment engages in the nuclear power generation activities. The others segment sells energy to companies and offers energy management services and solutions The company was formerly known as GDF SUEZ S.A. and changed its name to ENGIE SA in April 2015. The company was founded in 1880 and is headquartered in Courbevoie, France.
Earnings Per Share
As for profitability, ENGIE has a trailing twelve months EPS of €-0.71.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.41%.
Moving Average
ENGIE’s value is higher than its 50-day moving average of €13.28 and way above its 200-day moving average of €12.77.
Volatility
ENGIE’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.09%, a negative 0.08%, and a positive 1.22%.
ENGIE’s highest amplitude of average volatility was 1.30% (last week), 1.31% (last month), and 1.22% (last quarter).
Yearly Top and Bottom Value
ENGIE’s stock is valued at €14.16 at 17:50 EST, below its 52-week high of €14.68 and way higher than its 52-week low of €9.79.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ENGIE’s stock is considered to be oversold (<=20).
More news about ENGIE.
3. KBC (KBC.BR)
4.94% Foward Dividend Yield
KBC’s last close was €61.56, 15.04% below its 52-week high of €72.46. Intraday change was 2.6%.
KBC Group NV, together with its subsidiaries, provides integrated bank-insurance services primarily for retail, private banking, small and medium sized enterprises, and mid-cap clients. The company offers demand deposits and savings accounts; home and mortgage loans; consumer finance and SME funding services; credit, investment fund and asset management, and life and non-life insurance; and cash management, payments, trade finance, lease, money market, capital market products, and stockbroking services. It also provides Internet and mobile banking services. The company was formerly known as KBC Bank and Insurance Holding Company NV and changed its name to KBC Group NV in March 2005. KBC Group NV was incorporated in 1935 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, KBC has a trailing twelve months EPS of €3.34.
PE Ratio
KBC has a trailing twelve months price to earnings ratio of 18.91. Meaning, the purchaser of the share is investing €18.91 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.02%.
Volatility
KBC’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.43%, a negative 1.17%, and a positive 1.31%.
KBC’s highest amplitude of average volatility was 1.36% (last week), 2.10% (last month), and 1.31% (last quarter).
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 9, 2023, the estimated forward annual dividend rate is 3 and the estimated forward annual dividend yield is 4.94%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.9%, now sitting on 8.46B for the twelve trailing months.
Moving Average
KBC’s worth is under its 50-day moving average of €67.51 and way above its 200-day moving average of €56.56.
More news about KBC.
4. SANOFI (SAN.PA)
3.47% Foward Dividend Yield
SANOFI’s last close was €100.00, 6.24% below its 52-week high of €106.66. Intraday change was 1%.
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €9.68.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 10.43. Meaning, the purchaser of the share is investing €10.43 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.77%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
SANOFI’s EBITDA is 2.64.
Volatility
SANOFI’s last week, last month’s, and last quarter’s current intraday variation average was 2.72%, 0.64%, and 0.86%.
SANOFI’s highest amplitude of average volatility was 2.72% (last week), 1.02% (last month), and 0.86% (last quarter).
Moving Average
SANOFI’s worth is way above its 50-day moving average of €89.58 and way higher than its 200-day moving average of €88.42.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SANOFI’s stock is considered to be oversold (<=20).
More news about SANOFI.
5. ROTHSCHILD & CO (ROTH.PA)
3% Foward Dividend Yield
ROTHSCHILD & CO’s last close was €46.55, 3.12% under its 52-week high of €48.05. Intraday change was 0.43%.
Rothschild & Co SCA provides global advisory, wealth and asset management, and merchant banking services in France, the United Kingdom, the Channel Islands, the Americas, rest of Europe, Switzerland, Australia, Asia, and internationally. The company offers merger and acquisition, strategic advisory; debt advisory and restructuring; and equity advisory services, which include ECM advisory, private capital, and investor advisory and marketing services. It also provides wealth management services to successful families, individuals, foundations and charities; and asset management services, such as bespoke investment management and advisory services to institutional clients, financial intermediaries, and third-party distributors. In addition, the company offers merchant banking services, including corporate private equity, multi strategies, direct lending, and credit management. Rothschild & Co SCA was founded in 1838 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, ROTHSCHILD & CO has a trailing twelve months EPS of €2.19.
PE Ratio
ROTHSCHILD & CO has a trailing twelve months price to earnings ratio of 21.35. Meaning, the purchaser of the share is investing €21.35 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.08%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 6%, now sitting on 2.96B for the twelve trailing months.
Yearly Top and Bottom Value
ROTHSCHILD & CO’s stock is valued at €46.75 at 17:50 EST, below its 52-week high of €48.05 and way higher than its 52-week low of €30.60.
Moving Average
ROTHSCHILD & CO’s worth is higher than its 50-day moving average of €44.48 and way higher than its 200-day moving average of €37.64.
More news about ROTHSCHILD & CO.
6. CEGEDIM (CGM.PA)
2.91% Foward Dividend Yield
CEGEDIM’s last close was €19.68, 24.31% under its 52-week high of €26.00. Intraday change was -1.93%.
Cegedim SA operates as a technology and services company in the digital data flow management for healthcare ecosystem and B2B, and business software publisher for healthcare and insurance professionals worldwide. It operates in two divisions, Health Insurance, HR and e-Services; and Healthcare Professionals. The Health Insurance, HR and e-Services division markets various products and services to insurance companies, mutual insurers, personal protection insurers, and insurance brokers, as well as engages in the interactions between these entities and healthcare professionals. This division also provides solutions for hosting, HR and payroll management outsourcing, and electronic data exchange services. The Healthcare Professionals division offers management software, databases, and solutions to doctors, allied health professionals, pharmacists, and healthcare facilities. The company was incorporated in 1969 and is headquartered in Boulogne-Billancourt, France. Cegedim SA is a subsidiary of FCB SA.
Earnings Per Share
As for profitability, CEGEDIM has a trailing twelve months EPS of €1.01.
PE Ratio
CEGEDIM has a trailing twelve months price to earnings ratio of 19.11. Meaning, the purchaser of the share is investing €19.11 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.5%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.2%, now sitting on 555.21M for the twelve trailing months.
Volatility
CEGEDIM’s last week, last month’s, and last quarter’s current intraday variation average was 3.71%, 0.89%, and 1.61%.
CEGEDIM’s highest amplitude of average volatility was 3.71% (last week), 1.85% (last month), and 1.61% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CEGEDIM’s stock is considered to be oversold (<=20).
Yearly Top and Bottom Value
CEGEDIM’s stock is valued at €19.30 at 17:50 EST, way under its 52-week high of €26.00 and way higher than its 52-week low of €13.56.
More news about CEGEDIM.
